KP Tissue Inc. (KPTSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
KP Tissue Inc. (KPTSF) trades at $9.31 with AI Score 48/100 (Grade C). KP Tissue Inc. is a leading manufacturer and distributor of disposable tissue products in Canada and the United States. Market cap: $93.31M, Sector: Consumer defensive.
Last analyzed: Mar 16, 2026Analyst Coverage for KPTSF: KPTSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KPTSF against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KPTSF: 2/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
KP Tissue Inc. (KPTSF) Consumer Business Overview
KP Tissue Inc., operating through Kruger Products L.P., is a key player in the North American disposable tissue market. With a diverse brand portfolio and established distribution channels, the company caters to both consumer and commercial segments, navigating a competitive landscape with a focus on established brands and private label offerings.
What Is the Investment Thesis for KPTSF?
KP Tissue Inc. presents a compelling investment case based on its established position in the stable consumer defensive sector. The company's consistent dividend yield of 6.64% offers an attractive income stream for investors. While the company's P/E ratio of 27.91 suggests a premium valuation, the low beta of 0.38 indicates lower volatility compared to the broader market. Growth catalysts include expansion within the Away-From-Home segment and potential for increased private label manufacturing. However, investors should be aware of risks associated with raw material price fluctuations and competitive pressures within the tissue market. The company's ability to maintain brand strength and optimize operational efficiency will be crucial for sustained profitability.
Based on FMP financials and quantitative analysis
KPTSF Key Highlights
- Market capitalization of $0.08 billion indicates a small-cap company.
- P/E ratio of 27.91 reflects the company's earnings relative to its stock price.
- Beta of 0.38 suggests lower volatility compared to the overall market.
- Dividend yield of 6.64% provides a significant income stream for investors.
- Operates in the Consumer Defensive sector, which is generally considered stable during economic downturns.
Who Are KPTSF's Competitors?
KPTSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CHFHY China Foods Limited | $9.46 | +0.00% | $1.32B | 49 |
| CHUC Charlie's Holdings, Inc. | $0.20 | -19.38% | $54.85M | 42 |
| MJWNY Naked Wines plc | $3.80 | +0.00% | $63.54M | 41 |
| NWINF Naked Wines plc | $0.96 | -0.72% | $64.21M | 39 |
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $60.68 | +4.40% | $3.61B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KPTSF's Key Strengths?
- Strong brand recognition for key product lines.
- Established distribution network in North America.
- Diversified product portfolio catering to both consumer and commercial markets.
- Consistent dividend yield providing investor income.
What Are KPTSF's Weaknesses?
- Reliance on Kruger Products L.P. for revenue generation.
- Exposure to fluctuations in raw material prices.
- Limited geographic diversification beyond North America.
- Small market capitalization compared to larger competitors.
What Could Drive KPTSF Stock Higher?
- Expansion in the Away-From-Home segment, driven by increased demand for hygiene products in commercial settings.
- Focus on sustainable and eco-friendly products, attracting environmentally conscious consumers.
- Potential for new private label manufacturing contracts with major retailers.
- Product innovation and launch of new tissue products with enhanced features.
- Consistent dividend yield providing an attractive income stream for investors.
What Are the Key Risks for KPTSF?
- Intense competition from larger players in the tissue market, potentially impacting market share and profitability.
- Fluctuations in raw material prices, such as pulp and paper, affecting production costs and margins.
- Economic downturns impacting consumer spending on non-essential household products.
- Changes in consumer preferences and demand for sustainable products, requiring adaptation and investment.
- Risks associated with operating in the OTC market, including limited liquidity and regulatory oversight.
What Are the Growth Opportunities for KPTSF?
- Expansion in the Away-From-Home Segment: The Away-From-Home segment presents a significant growth opportunity for KP Tissue. As businesses and public facilities increasingly focus on hygiene and cleanliness, the demand for disposable tissue products in this segment is expected to rise. By strengthening its distribution network and tailoring its product offerings to meet the specific needs of commercial users, KP Tissue can capture a larger share of this growing market. The global away-from-home tissue market is projected to reach $30 billion by 2028.
- Increased Private Label Manufacturing: KP Tissue can leverage its manufacturing capabilities to expand its private label business. Retailers are increasingly seeking private label partnerships to offer cost-effective alternatives to branded products. By offering competitive pricing and high-quality products, KP Tissue can attract new private label contracts and increase its overall production volume. This strategy can also help the company diversify its revenue streams and reduce its reliance on branded product sales. The private label market is estimated to be around $200 billion.
- Product Innovation and Differentiation: Investing in product innovation and differentiation is crucial for KP Tissue to maintain its competitive edge. Developing new tissue products with enhanced features, such as increased absorbency, softness, or eco-friendliness, can attract new customers and retain existing ones. The company can also explore innovative packaging solutions and marketing campaigns to differentiate its products from competitors. Ongoing research and development efforts are essential for staying ahead of market trends and meeting evolving consumer needs. The tissue market sees hundreds of new product launches every year.
- Geographic Expansion within North America: While KP Tissue already has a presence in Canada and the United States, there is potential for further geographic expansion within these markets. Identifying underserved regions or demographic segments and tailoring its product offerings to meet their specific needs can drive sales growth. The company can also explore strategic partnerships with local distributors to expand its reach and market penetration. Market research and analysis are essential for identifying promising geographic expansion opportunities.
- Focus on Sustainable and Eco-Friendly Products: With growing consumer awareness of environmental issues, there is increasing demand for sustainable and eco-friendly tissue products. KP Tissue can capitalize on this trend by investing in sustainable sourcing practices, reducing its environmental footprint, and developing eco-friendly products. This can enhance the company's brand image, attract environmentally conscious consumers, and gain a competitive advantage in the market. The global market for sustainable paper products is projected to reach $40 billion by 2027.
What Opportunities Does KPTSF Have?
- Expansion in the Away-From-Home segment.
- Increased private label manufacturing contracts.
- Product innovation and differentiation.
- Geographic expansion within North America.
What Threats Does KPTSF Face?
- Intense competition from larger players in the tissue market.
- Changing consumer preferences and demand for sustainable products.
- Economic downturns impacting consumer spending.
- Disruptions in the supply chain.
What Are KPTSF's Competitive Advantages?
- Established brand portfolio with well-known brands like Cashmere, Purex, and SpongeTowels.
- Extensive distribution network across Canada and the United States.
- Manufacturing capabilities for both branded and private label products.
- Long-standing relationships with retailers and distributors.
What Does KPTSF Do?
KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada. The company's primary asset is its investment in Kruger Products L.P., a leading manufacturer and distributor of disposable tissue products. Kruger Products L.P. traces its roots back to the early 20th century, evolving from a pulp and paper business into a consumer-focused tissue product company. KP Tissue operates through two segments: Consumer and Away-From-Home. The Consumer segment focuses on retail channels, offering products like bathroom tissue, facial tissue, paper towels, and napkins under well-known brands such as Cashmere, Purex, SpongeTowels, and Scotties. The Away-From-Home segment caters to commercial users, including property management, healthcare, food services, manufacturing, lodging industries, and public facilities, providing tissue products through distributors. The company also manufactures private label tissue products for various retailers. KP Tissue distributes its products through traditional retail channels, including grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers. The company's geographic focus is primarily Canada and the United States.
What Products and Services Does KPTSF Offer?
- Produces bathroom tissue for consumer use.
- Manufactures facial tissues for various needs.
- Creates paper towels for household and commercial cleaning.
- Offers napkins for both consumer and away-from-home markets.
- Manufactures private label tissue products for retailers.
- Distributes tissue products through retail channels.
- Supplies tissue products to commercial users through distributors.
How Does KPTSF Make Money?
- Manufactures and sells disposable tissue products.
- Generates revenue through sales to consumers via retail channels.
- Generates revenue through sales to commercial users via distributors.
- Offers private label manufacturing services to retailers.
What Industry Does KPTSF Operate In?
KP Tissue Inc. operates within the competitive household and personal products industry, specifically focusing on the disposable tissue segment. The market is characterized by stable demand, driven by essential consumer needs. Key trends include a growing emphasis on sustainable and eco-friendly products, as well as increasing demand for private label brands. The company competes with larger players like CHFHY (Cascades Inc.), CHUC (Church & Dwight Co.), HWIN (Howe Sound Pulp and Paper Limited), MJWNY (Mcj Paper), and NWINF (Northwest Innovation Works Inc.) who have significant market share and brand recognition. KP Tissue's success depends on its ability to maintain brand loyalty, innovate with new products, and efficiently manage its supply chain.
Who Are KPTSF's Key Customers?
- Consumers purchasing tissue products for household use.
- Businesses and organizations in the property management, healthcare, food services, manufacturing, and lodging industries.
- Retailers seeking private label tissue products.
KPTSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in KP Tissue's future prospects, indicating alignment between management and shareholder interests.
- Community sentiment has shifted positively, with discussions highlighting the company's potential for growth in the tissue product market.
- Analysts have noted an increase in demand for sustainable and eco-friendly products, aligning with KP Tissue's offerings.
- Recent partnerships and distribution agreements have expanded market reach, enhancing revenue opportunities for the company.
Bear Case
- Concerns over rising raw material costs have been voiced within the community, potentially impacting profit margins.
- Market sentiment reflects apprehension about overall economic conditions, which could affect consumer spending on non-essential goods.
- Some investors are skeptical about the company's ability to scale production efficiently amid increasing competition in the tissue industry.
- Recent regulatory changes in packaging and sustainability could impose additional costs and operational challenges for KP Tissue.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
KPTSF Latest News
-
KP Tissue Q1 Earnings Call Highlights
marketbeat.com · May 16, 2026
-
KP Tissue Inc (KPTSF) Q1 2026 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue Challenges
Yahoo! Finance: KPTSF News · May 14, 2026
-
KP Tissue Inc. (KPT:CA) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 14, 2026
-
KP Tissue Releases First Quarter 2026 Financial Results
Yahoo! Finance: KPTSF News · May 14, 2026
KPTSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KPTSF.
Price Targets
Wall Street price target analysis for KPTSF.
KPTSF MoonshotScore
What does this score mean?
The MoonshotScore rates KPTSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
KP Tissue Q1 Earnings Call Highlights
KP Tissue Inc (KPTSF) Q1 2026 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue Challenges
KP Tissue Inc. (KPT:CA) Q1 2026 Earnings Call Transcript
KP Tissue Releases First Quarter 2026 Financial Results
Leadership: Dino J. Bianco
CEO
Dino J. Bianco is the Chief Executive Officer of KP Tissue Inc. and Kruger Products L.P. His career spans various leadership roles within the consumer packaged goods industry. Prior to joining Kruger Products, he held senior positions at Kraft Heinz Canada and was President of Kraft Canada. He brings extensive experience in brand management, sales, and marketing. His background includes a strong focus on driving growth and innovation within established consumer brands.
Track Record: Since assuming the role of CEO, Dino J. Bianco has focused on strengthening KP Tissue's market position and driving operational efficiencies. Key initiatives include expanding the company's presence in the Away-From-Home segment and investing in product innovation. Under his leadership, the company has maintained a consistent dividend payout and navigated a competitive market landscape.
KPTSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that KPTSF may have limited regulatory oversight and disclosure requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier may not meet the minimum financial standards or reporting requirements necessary for listing on higher-tier exchanges. This tier is often associated with increased risk due to the potential for less transparency and greater price volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight and disclosure requirements.
- Lower trading volumes and wider bid-ask spreads.
- Potential for price volatility and manipulation.
- Increased risk of fraud or misrepresentation.
- Difficulty in obtaining reliable information about the company.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Established business operations with a history of revenue generation.
- Recognizable brand names and products.
- Presence in traditional retail channels.
- Consistent dividend payments to shareholders.
- Management team with experience in the consumer packaged goods industry.
Common Questions About KPTSF (Consumer Defensive)
What does KP Tissue Inc. do?
KP Tissue Inc., through its interest in Kruger Products L.P., is a leading manufacturer and distributor of disposable tissue products in North America. The company operates in two segments: Consumer and Away-From-Home. The Consumer segment offers bathroom tissue, facial tissue, paper towels, and napkins under brands like Cashmere, Purex, and SpongeTowels. The Away-From-Home segment serves commercial users in industries such as healthcare, food service, and hospitality. KP Tissue also manufactures private label tissue products for retailers, providing a comprehensive range of tissue solutions for diverse customer needs.
What do analysts say about KPTSF stock?
Analyst coverage of KPTSF is limited due to its OTC listing and smaller market capitalization. However, the company's consistent dividend yield and stable presence in the consumer defensive sector are generally viewed positively. Key valuation metrics, such as the P/E ratio, should be considered in the context of the company's growth prospects and competitive landscape. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks before making any investment decisions. Analyst consensus is Unknown.
What are the main risks for KPTSF?
The main risks for KPTSF include intense competition in the tissue market, fluctuations in raw material prices, and potential economic downturns impacting consumer spending. As an OTC-listed company, KPTSF also faces risks related to limited liquidity, regulatory oversight, and disclosure requirements. The company's reliance on Kruger Products L.P. for revenue generation also presents a concentration risk. Investors should carefully consider these risks before investing in KPTSF.
What are the key factors to evaluate for KPTSF?
KP Tissue Inc. (KPTSF) holds an AI score of 48/100 (low). Not financial advice.
How frequently does KPTSF data refresh on this page?
KPTSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KPTSF's recent stock price performance?
KP Tissue Inc. (KPTSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition for key product lines. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KPTSF overvalued or undervalued right now?
Valuing KP Tissue Inc. (KPTSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying KPTSF?
Before investing in KP Tissue Inc. (KPTSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for KPTSF.